Nu-Med Plus Free Cash Flow (FCF) History (NUMD)

Nu-Med Plus reported −$567,341 in free cash flow for fiscal 2019, a decrease of $94,748 from the previous fiscal year.

View full Nu-Med Plus company overview

Nu-Med Plus free cash flow by year

Nu-Med Plus annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20192019-12-31−$567,341−$94,748
20182018-12-31−$472,593−$42,083
20172017-12-31−$430,510−$247,603
20152015-12-31−$182,907−$23,549
20142014-12-31−$159,358$10,044
20132013-12-31−$169,402−$46,417
20122012-12-31−$122,985

Nu-Med Plus free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from −$169,402 to −$567,341, a net decrease of $397,939. Nu-Med Plus's latest reported quarter, Q3 2018, generated −$142,931 in free cash flow, a decrease of $100,553 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Nu-Med Plus filings at SEC.gov ↗